Patents by Inventor Hye-yun JEONG

Hye-yun JEONG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition comprising bio compound for treating cardiovascular disease
    Patent number: 9757356
    Abstract: A pharmaceutical composition and a method for preventing or treating a cardiovascular disease are provided. The pharmaceutical composition includes a BIO compound ((2?Z,3?E)-6-bromoindirubin-3?-oxime) or a pharmaceutically acceptable salt thereof as an active ingredient. The pharmaceutical composition can specifically act on different types of cells constituting heart tissues, that is, can induce the growth of cardiomyocytes, and can also inhibit proliferation of cardiac fibroblasts and strongly suppress inflammatory mediators in macrophages, thereby significantly recovering the tissues and functions of the heart after the onset of myocardial infarction. Therefore, the pharmaceutical composition can be effectively used to treat various cardiovascular diseases including myocardial infarction.
    Type: Grant
    Filed: July 29, 2016
    Date of Patent: September 12, 2017
    Assignee: CHONNAM NATIONAL UNIVERSITY HOSPITAL
    Inventors: Youngkeun Ahn, Yong Sook Kim, Hye-yun Jeong, Darren R. Williams, Da-Woon Jung
  • COMPOSITION COMPRISING BIO COMPOUND FOR TREATING CARDIOVASCULAR DISEASE
    Publication number: 20170100372
    Abstract: A pharmaceutical composition and a method for preventing or treating a cardiovascular disease are provided. The pharmaceutical composition includes a BIO compound ((2?Z,3?E)-6-bromoindirubin-3?-oxime) or a pharmaceutically acceptable salt thereof as an active ingredient. The pharmaceutical composition can specifically act on different types of cells constituting heart tissues, that is, can induce the growth of cardiomyocytes, and can also inhibit proliferation of cardiac fibroblasts and strongly suppress inflammatory mediators in macrophages, thereby significantly recovering the tissues and functions of the heart after the onset of myocardial infarction. Therefore, the pharmaceutical composition can be effectively used to treat various cardiovascular diseases including myocardial infarction.
    Type: Application
    Filed: July 29, 2016
    Publication date: April 13, 2017
    Applicant: CHONNAM NATIONAL UNIVERSITY HOSPITAL
    Inventors: Youngkeun AHN, Yong Sook KIM, Hye-yun JEONG, Darren R. WILLIAMS, Da-Woon JUNG